A miRNA Signature of Chemoresistant Mesenchymal Phenotype Identifies Novel Molecular Targets Associated with Advanced Pancreatic Cancer

• Alakesh Bera,

  Affiliation Department of Medicine, Division of Hematology and Oncology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America

  ⨯
• Kolaparthi VenkataSubbaRao,

  Affiliation Department of Medicine, Division of Hematology and Oncology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America

  ⨯
• Muthu Saravanan Manoharan,

  Affiliation Research and Development, Audie Murphy Veterans Administration Hospital, San Antonio, Texas, United States of America

  ⨯
• Ping Hill,

  Affiliation Department of Medicine, Division of Hematology and Oncology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America

  ⨯
• James W. Freeman

  * E-mail: freemanjw@uthscsa.edu

  Affiliations Department of Medicine, Division of Hematology and Oncology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America, Cancer Therapy and Research Center, Experimental and Developmental Therapeutics Program, San Antonio, Texas, United States of America, Research and Development, Audie Murphy Veterans Administration Hospital, San Antonio, Texas, United States of America

  ⨯